{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T01:58:03Z","timestamp":1789351083027,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.nbd.2004.07.011","type":"journal-article","created":{"date-parts":[[2004,9,17]],"date-time":"2004-09-17T15:08:02Z","timestamp":1095433682000},"page":"319-325","source":"Crossref","is-referenced-by-count":36,"title":["Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic mice"],"prefix":"10.1016","volume":"17","author":[{"given":"Fran","family":"Norflus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Nanje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire-Anne","family":"Gutekunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bejarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Hersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nbd.2004.07.011_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X","article-title":"Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis","volume":"49","author":"Almer","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2004.07.011_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2004.07.011_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/exnr.1998.6984","article-title":"Beneficial effects of lysine acetylsalicylate, a soluble salt of aspirin on motor performance in a transgenic model of amyotrophic lateral sclerosis","volume":"155","author":"Barneoud","year":"1999","journal-title":"Exp. Neurol."},{"issue":"17","key":"10.1016\/j.nbd.2004.07.011_bib4","doi-asserted-by":"crossref","first-page":"9701","DOI":"10.1073\/pnas.170280697","article-title":"Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease","volume":"97","author":"Carmichael","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.nbd.2004.07.011_bib5","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J. Neurosci."},{"issue":"19","key":"10.1016\/j.nbd.2004.07.011_bib6","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/hmg\/9.19.2811","article-title":"Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila","volume":"9","author":"Chan","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.nbd.2004.07.011_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington's disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.nbd.2004.07.011_bib8","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M109613200","article-title":"Characterization of a brain-enriched chaperone, MRJ, that inhibits huntingtin aggregation and toxicity independently","volume":"277","author":"Chuang","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2004.07.011_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/hs0102.101299","article-title":"Inhibition of glutamate release via recovery of ATP levels accounts or a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation","volume":"33","author":"Cristobal","year":"2002","journal-title":"Stroke"},{"issue":"20","key":"10.1016\/j.nbd.2004.07.011_bib10","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","article-title":"Therapeutic effects of cystamine in a murine model of Huntington's disease","volume":"22","author":"Dedeoglu","year":"2002","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.nbd.2004.07.011_bib11","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2004.07.011_bib12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacimide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"issue":"28","key":"10.1016\/j.nbd.2004.07.011_bib13","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"232","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2004.07.011_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockage of NF-\u03baB activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.nbd.2004.07.011_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/14656566.1.5.1053","article-title":"Rofecoxib","volume":"1","author":"Hillson","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.nbd.2004.07.011_bib16","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.nbd.2004.07.011_bib17","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1093\/hmg\/9.13.2009","article-title":"Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity","volume":"9","author":"Jana","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2004.07.011_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine","volume":"8","author":"Karpuj","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2004.07.011_bib19","series-title":"Survival analysis: a self-learning text","first-page":"83","article-title":"The Cox proportional hazards model and its characteristics","author":"Kleinbaum","year":"1996"},{"key":"10.1016\/j.nbd.2004.07.011_bib20","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1471-4159.2003.02160.x","article-title":"Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic model of amyotrophic lateral sclerosis","volume":"88","author":"Klivenyi","year":"2004","journal-title":"J. Neurorchem."},{"issue":"4","key":"10.1016\/j.nbd.2004.07.011_bib21","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1073\/pnas.97.4.1589","article-title":"Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins","volume":"97","author":"Krobitsch","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.nbd.2004.07.011_bib22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1460-9568.2001.01420.x","article-title":"The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainite-induced cell death in the rat hippocampus","volume":"13","author":"Kunz","year":"2001","journal-title":"Eur. J. Neurosci."},{"issue":"15","key":"10.1016\/j.nbd.2004.07.011_bib23","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","article-title":"Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease","volume":"20","author":"Lim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2004.07.011_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurologic phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2004.07.011_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0969-9961(03)00002-0","article-title":"Microglial activation and cell death induced by the mitochondrial toxin 3-nitropropionic acid: in vitro and in vivo studies","volume":"12","author":"Ryu","year":"2003","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.nbd.2004.07.011_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jnen\/60.2.161","article-title":"Early and progressive accumulation of reactive microglia in the Huntington disease brain","volume":"60","author":"Sapp","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.1016\/j.nbd.2004.07.011_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2004.07.011_bib30","first-page":"161","article-title":"Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice","volume":"60","author":"Schilling","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2004.07.011_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.nbd.2004.07.011_bib32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11926-001-0055-9","article-title":"Cox-2 inhibitors in rheumatoid arthritis","volume":"3","author":"Sundy","year":"2001","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"10.1016\/j.nbd.2004.07.011_bib25","first-page":"1120","article-title":"Inhibition of lens crystallin glycation and high molecular weight aggregate formation by aspirin in vitro and in vivo","volume":"30","author":"Swamy","year":"1989","journal-title":"Invest. Opthalmol. Visn. Sci."},{"key":"10.1016\/j.nbd.2004.07.011_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/jnnp.58.2.192","article-title":"Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease","volume":"58","author":"Swerdlow","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.nbd.2004.07.011_bib34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/11.9.1137","article-title":"Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin","volume":"11","author":"Wyttenbach","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2004.07.011_bib35","first-page":"586","article-title":"Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice","volume":"63","author":"Yao","year":"2003","journal-title":"Cancer Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996104001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996104001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T20:56:01Z","timestamp":1549227361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996104001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0969996104001585"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2004.07.011","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}